April 6, 2020

by Abby Dodge
KCTV Reporter

The Center for Pharmaceutical Research in Kansas City was selected as a clinical research site for one of two COVID-19 vaccine studies. There will be 40 participants in the first phase of the trial. Billy Hudson is one of them. “I hope everyone will be able to be immune to this disease, including myself,” Hudson said.

The center is still looking for healthy participants but says those who have volunteered are passionate about prevention.
Read more and watch the coverage at KCTV.